Presentation TCT 2025 Cephea™ Mitral Valve System for Symptomatic Mitral Valve Disease: 1-Year Outcomes of the Early Feasibility Study Presenter: Torsten P. Vahl October 27, 2025
Presentation TCT 2024 Variations in New Clinical Trial Designs for Emerging CEP Devices Presenter: Alexandra Lansky October 30, 2024
Presentation TCT 2024 Novel Technologies in CEP During TAVR: Emboliner, ProTembo, Emblok, Filterex, and Others Presenter: Tamim Nazif October 30, 2024
Presentation TCT 2024 Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease Presenter: Pradeep Yadav October 29, 2024
Presentation TCT 2024 Incidence, Diagnosis, and Management of Evolving Strokes After TAVR Presenter: Julia Seeger October 28, 2024
Presentation TCT 2024 A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices Presenter: Aakriti Gupta October 28, 2024
Presentation TCT 2024 CEP Technology Landscape and Study Design Presenter: Mathew Williams October 28, 2024
Presentation TCT 2023 Point: PROTECTED TAVR – The Case for CEPD Presenter: Axel Linke October 26, 2023
Presentation TCT 2022 New and Novel CEP Devices: Differentiating Features Presenter: Giora Weisz September 17, 2022
Presentation TCT 2022 The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned Presenter: Axel Linke September 17, 2022
Presentation TCT 2019 Transseptal III: Cephea — Device Description, Results, and Ongoing Studies Presenter: Thomas Modine September 28, 2019
Presentation TCT 2017 Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans Presenter: Juan F. Granada October 31, 2017
Presentation TCT 2015 Cephea: Novel Design Features and Clinical Updates Presenter: Juan F. Granada October 12, 2015
Presentation TCT 2014 Transcatheter Mitral Valves Under Development II: Cephea Presenter: Juan F. Granada September 14, 2014